Abstract:OBJECTIVE:To investigate the biology of HeLa cells upon inhibition of human telomerase catalytic subunit (hTERT) gene by RNA interference in vitro.METHODS:Four shRNAs (A, B, C and D) targeting hTERT gene were designed and prepared by in-vitro transcription. The expression of hTERT gene was evaluated by immunofluorescent staining and telomeric repeat amplification protocol (TRAP) ELISA (TRAP-ELISA), after transient transfection of shRNAs by lipid formulation. Through the initial selection, shRNA (B) was noticed as the most efficient one in down-regulating hTERT gene and therefore was chosen as the ultimate shRNA used in the experimental groups. Those transfected by non-silencing RNAi were chosen as the control groups. Cell spreading and migration were studied by microscopy and cell adhesion to fibronectin (FN) was assayed by cell counting kit-8 (CCK-8). Cell invasion was assessed by Boyden chamber assay.RESULTS:Cell spreading study revealed that the rates of spreading cells in the experimental groups were (5.6 +/- 2.3)% at 30 min, and (26.3 +/- 6.1)% 2 h after the inoculation, respectively, whereas the rates of spreading cells in the control groups were (31.3 +/- 7.9)% and (79.4 +/- 4.8)%, respectively. There were significant differences between the two groups (P < 0.01). However, most of the cells in both groups became spreading after 24 h. Cell adhesion assay demonstrated that the rate of adhesion cells on FN in experimental groups was (67.2 +/- 2.8)%, less than that in control groups (83.7 +/- 5.4)% (P < 0.05). The relative migration distance was (27.1 +/- 6.2)% in the experimental group, lower than that of the control group (58.7 +/- 15.0)%. The invasion assay revealed that the invading cells were 75.7 +/- 14.5 in the experimental group, in contrast to 165.1 +/- 11.0 in the control group after 4 h incubation on matrigel. The difference between these two groups was significant (P < 0.05).CONCLUSION:In vitro shRNA silencing of hTERT gene can down-regulate the telomerase activity, leading to an inhibition of the malignant phenotype of HeLa cells, including decreased ability of cell spreading and adhesion, reduction of cell migration, and declined invasive ability through Matrige assay.

HuB and HuD repress telomerase activity by dissociating HuR from TERC

HuB and HuD repress telomerase activity by dissociating HuR from <i>TERC</i>

An Activity Switch in Human Telomerase Based on RNA Conformation and Shaped by TCAB1

HuR regulates telomerase activity through TERC methylation

Correction To: HnRNP F/H Associate with Hterc and Telomerase Holoenzyme to Modulate Telomerase Function and Promote Cell Proliferation

TERC Suppresses PD-L1 Expression by Downregulating RNA Binding Protein HuR

PCDH10 Interacts with Htert and Negatively Regulates Telomerase Activity

Distinct and temporal roles of nucleosomal remodeling and histone deacetylation in the repression of the hTERT gene.

Transforming Growth Factor β Suppresses Human Telomerase Reverse Transcriptase (hTERT) by Smad3 Interactions with c-Myc and the hTERT Gene

TERC Promotes Non-Small Cell Lung Cancer Progression by Facilitating the Nuclear Localization of TERT

Transcriptional Regulation of Telomerase Activity

Author Correction: HuR Regulates Telomerase Activity Through TERC Methylation

The Putative Tumor Suppressor C53 Interacts with the Human Telomerase Reverse Transcriptase Htert and Regulates Telomerase Activity

An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase

hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells.

[Inhibition of Malignant Phenotype of HeLa Cells by RNA Interference of the Telomerase Activity].

RNA binding protein HuD promotes autophagy and tumor stress survival by suppressing mTORC1 activity and augmenting ARL6IP1 levels

Nucleolar localization of TERT is unrelated to telomerase function in human cells.

Αcp1 Mediates Stabilization of Htert Mrna by Autocrine Human Growth Hormone

Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene

HuR stabilizes HTT mRNA via interacting with its exon 11 in a mutant HTT-dependent manner.